SCHEMBL310074

SCHEMBL310074

OCCc1cc[nH]c1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Ether SCHEMBL27618516 0.86 CAPN1 (0.44)
SCHEMBL2003673 0.86
Pyridine SCHEMBL28215863 0.84 CAPN1 (0.43)
SCHEMBL7290866 0.82 CAPN1 (0.48)
SCHEMBL1162272 0.79
SCHEMBL24445986 0.76 TDP1 (0.47)
SCHEMBL6674645 0.75
SCHEMBL9746748 0.75
SCHEMBL2273992 0.75
SCHEMBL2007361 0.75

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 74 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3724191-A1 5-(2-(2,5-DIFLUOROPHENYL)PYRROLIDIN-1 -YL)-3-(1H-PYRAZOL-1-YL)PYRAZOLO[1,5-A]PYRIMIDINE DERIVATIVES AND RELATED COMPOUNDS AS TRK KINASE INHIBITORS FOR TREATING CANCER Pyramid Biosciences, Inc. (US) 2020-10-21 EP claimed
WO-2019118584-A1 5-(2-(2,5-DIFLUOROPHENYL)PYRROLIDIN-1 -YL)-3-(1H-PYRAZOL-1-YL)PYRAZOLO[1,5-A]PYRIMIDINE DERIVATIVES AND RELATED COMPOUNDS AS TRK KINASE INHIBITORS FOR TREATING CANCER PYRAMID BIOSCIENCES, INC. (US) 2019-06-20 WO claimed
EP-2178869-B1 INDOLE COMPOUNDS AS AN INHIBITOR OF CELLULAR NECROSIS LG LIFE SCIENCES LTD (KR) 2013-06-12 EP claimed
EP-0224723-B1 PROCESS FOR THE PREPARATION OF BETA-HYDROXYETHYL-AZOLE DERIVATIVES BAYER AG (DE) 1989-11-23 EP claimed
EP-4098798-B1 PROCESS FOR PREPARING A POLYMER-COATED TEXTILE HAVING OMNIPHOBIC PROPERTIES UNIV COTE D'AZUR (FR) 2024-03-27 EP disclosed
EP-4329889-A1 IL4I1 INHIBITORS AND METHODS OF USE Merck Sharp & Dohme LLC (US) 2024-03-06 EP disclosed
WO-2022253891-A1 PROCESS FOR PREPARING A POLYMER-COATED TEXTILE HAVING OMNIPHOBIC PROPERTIES UNIVERSITE COTE D'AZUR (FR) 2022-12-08 WO disclosed
EP-4098798-A1 PROCESS FOR PREPARING A POLYMER-COATED TEXTILE HAVING OMNIPHOBIC PROPERTIES Université Côte d'Azur (FR) 2022-12-07 EP disclosed
EP-4098798-A1 PROCESS FOR PREPARING A POLYMER-COATED TEXTILE HAVING OMNIPHOBIC PROPERTIES Université Côte d'Azur (FR) 2022-12-07 EP disclosed
WO-2022232333-A1 IL4I1 INHIBITORS AND METHODS OF USE MERCK SHARP & DOHME LLC (US) 2022-11-03 WO disclosed
US-20210102234-A1 PROCESS OF DIRECTLY DETECTING AND IDENTIFYING A MICROORGANISM IN A BIOLOGICAL SAMPLE DILUTED IN AN ENRICHMENT BROTH BIOMERIEUX SA (FR) 2021-04-08 US disclosed
US-10907190-B2 Process of directly detecting and identifying a microorganism in a biological sample diluted in an enrichment broth BIOMERIEUX S.A. (FR) 2021-02-02 US disclosed
WO-2004060904-A1 PYRROLES SUBSTITUTED BY OLIGONUCLEOTIDES BIOMERIEUX SA (FR) 2004-07-22 WO disclosed
EP-0708102-B1 5-HT1F agonists for the treatment of migraine LILLY CO ELI (US) 2002-12-11 EP disclosed
US-5721252-A PIPERIDINYL-1H-INDOLE DERIVATIVES ELI LILLY AND COMPANY (US) 1998-02-24 US disclosed
CN-1158610-A Quinoxaline derivatives useful in therapy PFIZER LTD (IE) 1997-09-03 CN disclosed
US-5521196-A ANALGESICS USING SEROTONIN ANTAGONIST ELI LILLY AND COMPANY (US) 1996-05-28 US disclosed
EP-0708102-A1 5-HT1F agonists for the treatment of migraine ELI LILLY AND COMPANY (US) 1996-04-24 EP disclosed
US-5204424-A CONDUCTIVE POLYMERS DERIVED FROM AROMATIC HETEROCYCLIC COMPOUNDS SUBSTITUTED BY AN ETHER-TYPE GROUP SOLVAY S.A. (BE) 1993-04-20 US disclosed
US-3996409-A High temperature adhesive-sealant composition PPG INDUSTRIES, INC. (US) 1976-12-07 US disclosed